📗 Cite This Artifact
RAB39B Gene
RAB39B — RAB39B, Member RAS Oncogene Family
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RAB39B Gene</th>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cortex</td>
<td>Medium-High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Medium</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Medium</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>RAB39B</td>
</tr>
<tr>
<td class="label">Primary location</td>
<td>Endo/lysosomes</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Multiple</td>
</tr>
<tr>
<td class="label">PD association</td>
<td>Yes</td>
</tr>
<tr>
<td class="label">Mutation Type</td>
<td>Example</td>
</tr>
<tr>
<td class="label">Nonsense</td>
<td>p.W71X</td>
</tr>
<tr>
<td class="label">Missense</td>
<td>p.G269R</td>
</tr>
<tr>
<td class="label">Splice site</td>
<td>c.1000+1G>A</td>
</tr>
<tr>
<td class="label">Deletion</td>
<td>Full gene</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">PARKINSON</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a></td>
</tr>
<tr>
<td class="label">KG
RAB39B — RAB39B, Member RAS Oncogene Family
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RAB39B Gene</th>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cortex</td>
<td>Medium-High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Medium</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Medium</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>RAB39B</td>
</tr>
<tr>
<td class="label">Primary location</td>
<td>Endo/lysosomes</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Multiple</td>
</tr>
<tr>
<td class="label">PD association</td>
<td>Yes</td>
</tr>
<tr>
<td class="label">Mutation Type</td>
<td>Example</td>
</tr>
<tr>
<td class="label">Nonsense</td>
<td>p.W71X</td>
</tr>
<tr>
<td class="label">Missense</td>
<td>p.G269R</td>
</tr>
<tr>
<td class="label">Splice site</td>
<td>c.1000+1G>A</td>
</tr>
<tr>
<td class="label">Deletion</td>
<td>Full gene</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">PARKINSON</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">16 edges</a></td>
</tr>
</table>
Overview
RAB39B (RAB39B, Member RAS Oncogene Family) is a member of the Rab GTPase family that plays critical roles in intracellular membrane trafficking, particularly within the endolysosomal system and at synapses. Mutations in RAB39B cause a distinctive form of X-linked early-onset Parkinson's disease associated with intellectual disability, known as Waisman syndrome or X-linked parkinsonism with intellectual disability[@wilson2014].
RAB39B is predominantly expressed in the brain, with highest levels in the substantia nigra, hippocampus, and cerebral cortex. The protein localizes to endosomes, lysosomes, and synaptic vesicles, where it regulates trafficking pathways essential for neuronal function and survival. The identification of RAB39B mutations as a cause of familial PD established endolysosomal dysfunction as a key pathway in neurodegeneration and expanded the genetic spectrum of parkinsonism to include atypical forms with developmental abnormalities.
Gene and Protein Structure
Gene Organization
The RAB39B gene is located on the X chromosome at Xq28 and consists of 8 exons spanning approximately 7.5 kb of genomic DNA. The gene encodes a protein of 235 amino acids with a molecular weight of approximately 26 kDa.
Protein Domain Architecture
RAB39B contains the canonical Rab GTPase domain structure:
- GTP-binding domain (amino acids 1-60): The N-terminal domain containing the conserved GxxxxGKST and DxxG motifs that coordinate nucleotide binding and hydrolysis
- Switch I region (amino acids 35-50): Undergoes conformational changes upon GTP/GDP binding, critical for effector interactions
- Switch II region (amino acids 65-80): Another dynamic region involved in effector binding and GAP interaction
- Hypervariable region (amino acids 180-210): The C-terminal region that determines subcellular targeting specificity
- C-terminal cysteine motif (amino acids 230-235): CaaX motif (Cys-Ser-Ser-Met) that undergoes geranylgeranylation for membrane association
Post-Translational Modifications
RAB39B undergoes several post-translational modifications:
- Geranylgeranylation: Isoprenylation at the C-terminal cysteine is essential for membrane localization
- GTP/GDP cycling: The core regulatory mechanism controlling activity
- Phosphorylation: Some evidence suggests regulatory phosphorylation
Cellular Functions
Endolysosomal Trafficking
RAB39B plays a central role in endolysosomal system function:
Autophagy Regulation
RAB39B is essential for proper autophagic flux:
- Autophagosome formation: Contributes to the initiation of autophagosome biogenesis
- Autophagosome-lysosome fusion: Facilitates the fusion of autophagosomes with lysosomes[@gong2019]
- Lysosomal function: Maintains lysosomal acidic pH and degradative capacity
- Cargo clearance: Enables efficient clearance of protein aggregates and damaged organelles
Synaptic Function
At the synapse, RAB39B regulates:
- Synaptic vesicle trafficking: Coordinates synaptic vesicle cycling
- Neurotransmitter release: Regulates quantal content and release probability
- Synaptic plasticity: Required for long-term potentiation and memory formation[@gao2019]
- Synaptic protein localization: Maintains proper distribution of synaptic components
Mitochondrial Dynamics
RAB39B influences mitochondrial function through:
- Mitochondrial distribution: Controls axonal mitochondrial positioning
- Mitophagy: Facilitates the selective autophagy of damaged mitochondria
- Mitochondrial quality control: Helps maintain mitochondrial health
- Energy metabolism: Supports synaptic energy demands
Role in Parkinson's Disease
Genetics
RAB39B mutations cause X-linked parkinsonism with intellectual disability:
- Inheritance: X-linked recessive; primarily affects males
- Mutation types: Nonsense, missense, splice site, and whole gene deletions
- Key mutations: p.W71X (nonsense), p.G269R (missense)[@macieszak2016]
- Age of onset: Early onset (age 12-30 years)
The clinical phenotype is characterized by early-onset parkinsonism with prominent intellectual disability, developmental delay, and often additional neurological features including speech impairment and sometimes macrocephaly.
Phenotype
Patients with RAB39B mutations present with:
- Parkinsonism: Bradykinesia, rigidity, tremor (often asymmetric)
- Intellectual disability: Varying severity, present from childhood
- Developmental delay: Motor and speech delays in early development
- Additional features: May include seizures, ataxia, or psychiatric symptoms
- Progression: Progressive motor decline over time
Pathogenic Mechanisms
RAB39B mutations cause disease through loss-of-function:
Molecular Interactions
RAB39B Effectors
RAB39B interacts with several effector proteins:
- WASH complex: The WASH (Wiskott-Aldrich syndrome protein and SCAR homologue) complex is recruited by RAB39B and regulates actin polymerization on endosomes[@olszewski2019]
- Retromer complex: Coordinates endosomal cargo sorting
- HOPS complex: Facilitates lysosomal fusion events
- VAMP7/VAMP8: SNARE proteins involved in membrane fusion
- Mitochondrial proteins: Interactions with mitophagy machinery
Regulation
RAB39B activity is regulated by:
- GEFs: RABGEF1 (Rabconnectin-3) is the major GEF activating RAB39B
- GAPs: GTPase-activating proteins that inactivate RAB39B
- GDIs: GDP dissociation inhibitors that regulate membrane cycling
Interaction with Other PD Genes
RAB39B intersects with several other Parkinson's disease genes:
- LRRK2: RAB39B and LRRK2 may cooperate in endosomal trafficking[@correia2021]
- GBA: Lysosomal dysfunction in RAB39B deficiency overlaps with GBA-related pathways
- DNAJC13: Both regulate endosomal trafficking
- VPS35: Part of the retromer pathway that works with RAB39B
Neuroanatomical Expression
Brain Expression Pattern
RAB39B shows characteristic expression in:
- Substantia nigra pars compacta: Highest expression in dopaminergic neurons
- Striatum: Moderate expression in medium spiny neurons
- Cerebral cortex: Layer 5 pyramidal neurons show strong expression
- Hippocampus: CA1 and CA3 pyramidal neurons, dentate gyrus
- Cerebellum: Purkinje cells
This expression pattern explains the selective vulnerability of dopaminergic neurons in RAB39B-related disease.
Brain Region Expression Levels
Research Models
Cellular Models
Within neurons, RAB39B localizes to:
- Endosomal compartments: Early and recycling endosomes
- Lysosomes: Late endosomal/lysosomal compartments
- Synaptic vesicles: Presynaptic vesicle pools
- Axonal compartments: Particularly in distal axons and terminals
Research Models
Cellular Models
- Patient-derived iPSC neurons: Dopaminergic neurons from RAB39B mutation carriers show:
- Impaired neurite outgrowth
- Reduced neurite complexity
- Altered autophagy flux
- Mitochondrial dysfunction
- Increased sensitivity to oxidative stress[@zhang2021]
- Overexpression/knockdown systems: SH-SY5Y cells and primary neurons
- Knockout cell lines: CRISPR-derived cell lines with RAB39B deletion
Animal Models
- Rab39b knockout mice: Show age-dependent motor dysfunction
- Reduced striatal dopamine levels
- Accumulation of autophagic markers
- Progressive loss of dopaminergic neurons
- Cognitive deficits
- Zebrafish models: Demonstrate developmental defects
- Drosophila models: Show synaptic and behavioral phenotypes
Therapeutic Implications
Gene Therapy Approaches
- AAV-mediated RAB39B delivery: Viral vector delivery to restore expression
- CRISPR-based editing: Correction of pathogenic mutations
- Allele-specific silencing: For dominant-negative mutations (if any)
Small Molecule Approaches
- Autophagy enhancers: mTOR inhibitors, rapamycin analogs
- Trafficking modulators: Compounds that enhance compensatory pathways
- Neuroprotective agents: Antioxidants, anti-inflammatory compounds
Target Validation
Key therapeutic targets include:
Signaling Pathways
Endosomal Signaling
RAB39B-containing endosomes serve as signaling platforms:
- Nutrient signaling: mTORC1 localization to lysosomes is regulated by amino acid sensing
- Growth factor signaling: Receptor tyrosine kinase signaling from endosomes
- Wnt signaling: Endosomal trafficking modulates Wnt pathway components
Synaptic Signaling
At synapses, RAB39B affects:
- Presynaptic plasticity: Regulates release probability
- Retrograde signaling: Controls retrograde signaling from terminals
- Postsynaptic responses: Modulates receptor trafficking
Neuroimmune Interactions
RAB39B may influence neuroinflammation:
- Microglial function: RAB39B in microglia affects debris clearance
- Cytokine regulation: Alters inflammatory cytokine production
- Blood-brain barrier: May affect endothelial cell function
Protein-Protein Interaction Network
RAB39B Interactome
Key interactors include:
- WASH complex (WASH, FAM21, WASHC2A, WASHC4, WASHC5)
- Retromer complex (VPS26, VPS29, VPS35)
- SNARE proteins (VAMP7, VAMP8)
- HOPS complex (VPS16, VPS18, VPS33A/B)
- RABGEF1 (activating factor)
Trafficking Pathways
RAB39B operates in several trafficking pathways:
Comparison with Other Rab Proteins
RAB39B vs Related Rabs
Functional Overlap
RAB39B has some functional redundancy with:
- RAB5: Early endosome function
- RAB7: Late endosome/lysosome function
- RAB39A: Synaptic function (brain-expressed paralog)
Clinical Management
Diagnosis
Diagnostic workup includes:
Treatment Approaches
Current treatment strategies:
- Levodopa/carbidopa: Dopaminergic replacement
- Dopamine agonists: Pramipexole, ropinirole
- MAO-B inhibitors: Selegiline, rasagiline
- Physical therapy: For motor symptoms
- Speech therapy: For communication difficulties
- Educational support: For intellectual disability
Long-Term Care
Patients require:
- Regular neurological assessment
- Motor function monitoring
- Cognitive assessment
- Psychiatric evaluation
- Genetic counseling
Comparative Neurobiology
Species Distribution
RAB39B is conserved across vertebrates:
- Mammals: Highly conserved sequence
- Birds: Expressed in brain
- Zebrafish: Ortholog expressed in CNS
- Invertebrates: No clear ortholog
Evolutionary Insights
The emergence of RAB39B coincides with increased complexity of the endolysosomal system in vertebrates, suggesting specialized neuronal functions evolved to support more complex synaptic circuits.
Neurodevelopmental Aspects
Developmental Expression
RAB39B expression during development:
- Embryonic brain: Low expression in early development
- Postnatal: Increases significantly after birth
- Adult: Highest expression in neurons
This developmental pattern suggests RAB39B may be particularly important for postnatal brain maturation and maintenance.
Impact on Neural Circuit Formation
RAB39B deficiency affects:
- Neuronal maturation: Impaired dendritic arborization
- Synapse formation: Reduced synapse density
- Circuit refinement: Abnormal connectivity
- Myelination: Potential effects on white matter
Biomarkers and Diagnostics
Current Biomarkers
- Genetic testing: Confirms diagnosis
- Neuroimaging: MRI shows brain structure
- DaTscan: Shows dopaminergic deficit
Emerging Biomarkers
- CSF biomarkers: Neurofilament light chain
- Blood markers: Inflammation markers
- Expression studies: RAB39B levels in blood
Research Methodology
Model Systems
Experimental Approaches
- Live-cell imaging: Tracking endosomal dynamics
- Electrophysiology: Assessing synaptic function
- Proteomics: Mapping interactome
- Transcriptomics: Gene expression analysis
Therapeutic Pipeline
Preclinical Development
Current approaches in development:
Challenges
- Blood-brain barrier: Delivery to CNS
- Target specificity: Avoiding off-target effects
- Efficacy: Ensuring adequate target engagement
- Safety: Long-term safety assessment
Cross-References
- [Parkinson's Disease](/diseases/parkinsons-disease) - Associated disease
- [Waisman Syndrome](/diseases/waisman-syndrome) - Associated syndrome
- [Endosomal Trafficking](/mechanisms/endosomal-trafficking) - Key mechanism
- [Autophagy](/mechanisms/autophagy) - Related pathway
- [LRRK2](/genes/lrrk2) - Related PD gene
- [Dopamine](/mechanisms/dopamine-signaling) - Affected neurotransmitter
- [Lysosomal Dysfunction](/mechanisms/lysosomal-dysfunction) - Related mechanism
Future Research Directions
Unresolved Questions
Key questions remain:
Research Priorities
- Model development: Better animal and cellular models
- Mechanism studies: Detailed molecular understanding
- Therapeutic screening: Drug discovery for RAB39B targeting
- Clinical trials: Planning for eventual therapeutic trials
Conclusion
RAB39B represents a critical link between endolysosomal trafficking dysfunction and neurodegeneration in Parkinson's disease. As one of the few genes causing parkinsonism with developmental features, RAB39B provides unique insight into the intersection of neuronal development and degeneration.
Key takeaways:
Future research will continue to illuminate RAB39B biology and develop effective treatments for affected individuals.
Genetic Epidemiology
Population Genetics
- Mutation frequency: Extremely rare; few families reported worldwide
- Ethnic distribution: Identified in multiple ethnic backgrounds
- Carrier frequency: Very low in general population
- Penetrance: High in males carrying pathogenic mutations
Genotype-Phenotype Correlations
Clinical Features
Diagnostic Criteria
RAB39B-related parkinsonism is diagnosed based on:
Differential Diagnosis
RAB39B-related disease must be distinguished from:
- Classic early-onset PD: Without intellectual disability
- Parkinsonism-plus syndromes: Plus features but no ID
- Other X-linked intellectual disabilities: Without parkinsonism
- Other genetic forms of parkinsonism: LRRK2, GBA, etc.
Management
Current management includes:
- Dopaminergic therapy: Levodopa may provide some benefit
- Developmental support: Early intervention for ID
- Speech therapy: For communication difficulties
- Physical therapy: For motor symptoms
- Monitoring: Regular assessment of motor and cognitive function
Cross-References
- [Parkinson's Disease](/diseases/parkinsons-disease) - Associated disease
- [Waisman Syndrome](/diseases/waisman-syndrome) - Associated syndrome
- [Endosomal Trafficking](/mechanisms/endosomal-trafficking) - Key mechanism
- [Autophagy](/mechanisms/autophagy) - Related pathway
- [LRRK2](/genes/lrrk2) - Related PD gene
- [Dopamine](/mechanisms/dopamine-signaling) - Affected neurotransmitter
See Also
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [X-linked Intellectual Disability](/diseases/intellectual-disability)
- [Endosomal Trafficking Pathways](/mechanisms/endosomal-traffishing)
- [Autophagy in Neurodegeneration](/mechanisms/autophagy)
- [Rab GTPases in Brain](/proteins/rab-gtpases)
External Links
- [GeneCards: RAB39B](https://www.genecards.org/cgi-bin/carddisp.pl?gene=RAB39B)
- [OMIM: RAB39B](https://www.omim.org/entry/300604)
- [UniProt: RAB39B](https://www.uniprot.org/uniprot/Q9BYE8)
- [GeneReviews: RAB39B Disorders](https://www.ncbi.nlm.nih.gov/books/NBK532283/)
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=RAB39B+Parkinson)
References
Pathway Diagram
The following diagram shows the key molecular relationships involving RAB39B Gene discovered through SciDEX knowledge graph analysis:
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-rab39b |
| kg_node_id | RAB39B |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-d7a0808cfe82 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-rab39b'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-rab39b?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[RAB39B Gene](http://scidex.ai/artifact/wiki-genes-rab39b)
http://scidex.ai/artifact/wiki-genes-rab39b